Loading clinical trials...
Loading clinical trials...
A Phase 1b, Multi-centered, Randomized, Double-blind, Placebo-controlled, Parallel Group, Three Sequential Part Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy
Conditions
Interventions
STMC-103H
Placebo
Locations
2
United States
Bensch Clinical Research LLC
Stockton, California, United States
Orange County Research Center
Tustin, California, United States
Start Date
October 10, 2018
Primary Completion Date
November 1, 2019
Completion Date
November 1, 2019
Last Updated
January 29, 2019
Lead Sponsor
Siolta Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions